Health & Safety Industry Today
Radioimmunoassay Market Poised to Hit USD 1.02 Billion by 2030, Driven by Rising Diagnostic Demand & Tech Innovation
Introduction
The radioimmunoassay market is on track for robust growth over the next five years, according to a recent report by Mordor Intelligence. Radioimmunoassay (RIA) techniques, known for their sensitivity and precision in measuring hormones, drugs, and other analytes, remain essential in both clinical diagnostics and research. With the The Radioimmunoassay Market size is estimated at USD 0.78 billion in 2025, and is expected to reach USD 1.02 billion by 2030, at a CAGR of 5.5% during the forecast period (2025-2030). Technological innovation, increasing healthcare infrastructure investment, and expanding applications across diagnostics are all contributing to this upward trajectory.
Key Trends
- Technological Advancements – Automation Integration:
- Automation and improved RIA reagents are enhancing test accuracy and throughput, supporting personalized medicine and targeted therapies.
- North America – Dominant Regional Market:
- Advanced healthcare infrastructure, high biopharma R&D investment, and a strong focus on precision diagnostics position North America as a key growth hub.
- Increased Diagnostic Demand:
- Growing prevalence of chronic conditions, especially cancer, is boosting the need for reliable and early diagnostic methods like RIA.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:
Market Segmentation
By Product
- Analyzers
- Reagents and Kits
By Application
- Research
- Clinical Diagnostics
By End User
- Hospitals
- Clinical Diagnostic Laboratories
- Pharmaceutical Industries
- Other End Users
Geography
- North America
- South America
- Europe
- Middle east&Africa
- Asia pacific
Explore Our Full Library of Healthcare Research Industry Reports - https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=Industrytoday.co.uk
Key Players
Key companies operating in the radioimmunoassay market include DIAsource ImmunoAssays SA, Danaher (Beckman Coulter, Inc.), Berthold Technologies GmbH & Co. KG, IBL International, and BioCheck, Inc. (DRG International Inc.), according to Mordor Intelligence.
Industry Related Reports:
Thyroid Function Test Market
Get More Insights: https://www.mordorintelligence.com/industry-reports/thyroid-function-test-market?utm_source=Industrytoday.co.uk
Asia-Pacific Autoimmune Disease Diagnostics Market :
Get More Insights: https://www.mordorintelligence.com/industry-reports/asia-pacific-autoimmune-disease-diagnostics-market-industry?utm_source=Industrytoday.co.uk
Europe Esoteric Testing Market
Get More Insights: https://www.mordorintelligence.com/industry-reports/europe-esoteric-testing-market?utm_source=Industrytoday.co.uk
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking actionable market insights. With 550+ domain experts and specialists across 150+ countries, we deliver comprehensive syndicated and custom research across industries such as aerospace, agriculture, chemicals, consumer goods, energy, healthcare, and many more, helping organizations make informed decisions and achieve strategic goals.
For any inquiries or to access the full report, please contact:
https://www.mordorintelligence.com/
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!
